FUJIREBIO NEURO CENTER OF EXCELLENCE Trademark

Trademark Overview


On Monday, June 6, 2022, a trademark application was filed for FUJIREBIO NEURO CENTER OF EXCELLENCE with the United States Patent and Trademark Office. The USPTO has given the FUJIREBIO NEURO CENTER OF EXCELLENCE trademark a serial number of 79351939. The federal status of this trademark filing is REGISTERED as of Tuesday, November 7, 2023. This trademark is owned by Fujirebio Inc.. The FUJIREBIO NEURO CENTER OF EXCELLENCE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research services for reagents for medical use in the field of neurology; research services for reagents for medical use; medical research and medical analysis for medical research in the field of neurology, and consulting relating thereto; analysis for medical research and medical research services and consulting about the aforesaid; scientific testing, analysis and research for medical purposes in the field of neurology; scientific testing, analysing and research for medical purposes in the field of neurology; scientific and medical research and development in the field of neurology; scientific and medical research and development in the field of neurology; testing, inspection and research of chemicals and pharmaceuticals in the field of neurology; testing, inspection and research of chemicals and pharmaceuticals; testing, inspection and research of cosmetics and foodstuffs; research and development in the field of diagnostic preparations relating to neurology; research and developme...
fujirebio neuro center of excellence

General Information


Serial Number79351939
Word MarkFUJIREBIO NEURO CENTER OF EXCELLENCE
Filing DateMonday, June 6, 2022
Status700 - REGISTERED
Status DateTuesday, November 7, 2023
Registration Number7209639
Registration DateTuesday, November 7, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 22, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized wording "FUJIREBIO NEURO CENTER OF EXCELLENCE" in black to the right of a black vertical line; a design of two hands outlined in blue sit below an incomplete circle design consisting of two halves; one side being a half of a brain outlined in green, and the other side being half of a globe outlined in blue. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark.
Indication of Colors claimedThe color(s) blue, green and black is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"NEURO CENTER OF EXCELLENCE"
Goods and ServicesResearch services for reagents for medical use in the field of neurology; research services for reagents for medical use; medical research and medical analysis for medical research in the field of neurology, and consulting relating thereto; analysis for medical research and medical research services and consulting about the aforesaid; scientific testing, analysis and research for medical purposes in the field of neurology; scientific testing, analysing and research for medical purposes in the field of neurology; scientific and medical research and development in the field of neurology; scientific and medical research and development in the field of neurology; testing, inspection and research of chemicals and pharmaceuticals in the field of neurology; testing, inspection and research of chemicals and pharmaceuticals; testing, inspection and research of cosmetics and foodstuffs; research and development in the field of diagnostic preparations relating to neurology; research and development in the field of diagnostic preparations; providing information relating to medical research in the field of medicine, chemistry and diagnostics relating to neurology; providing information relating to medical research in the field of medicine, chemistry and diagnostics; working on and evaluation of chemical analyses in the field of neurology; working on and evaluation of chemical analyses; consultancy in the field of chemistry relating to neurology; consultancy in the field of chemistry; testing, inspection and research of chemicals and pharmaceuticals relating to chemistry in the field of neurology; testing, inspection and research of diagnostic agents relating to chemistry; testing, inspection, research, evaluation and analysis of chemical ingredients in the field of neurology; testing, inspection, research, evaluation and analysis of chemical ingredients; product research and development services; product development consultancy; providing quality assurance services in the field of neurology; quality assurance consultancy services in the field of neurology; product quality testing; material testing and analysis for product quality; testing the functionality of, and research on, machines, apparatus and instruments; testing the functionality of, and research relating to, medical apparatus and instruments in the field of neurology, and their parts; testing the functionality of, and research relating to, medical apparatus and instruments and their parts; design of medical apparatus and instruments in the field of neurology; design of medical apparatus and instruments; design and development of diagnostic apparatus; design and development of medical diagnostic apparatus in the field of neurology; design and development of medical diagnostic apparatus; rental of laboratory apparatus for chemical substances in the field of neurology; rental of laboratory apparatus for chemical substances; rental of measuring apparatus; rental of measuring and laboratory machines and instruments; rental of laboratory apparatus and instruments; rental of computers; providing computer programs on data networks, namely, providing temporary use of online non-downloadable software for database management in the field of neurology; computer software design, computer programming, and maintenance of computer software; scientific and medical research and development in the field of neurology by collaborating with third parties; scientific and medical research and development by collaborating with third parties; scientific research, testing and analysis services by engineers and scientists, and their technological consultancy services in the field of neurology; pharmaceutical product evaluation by engineers and scientists, and its technological consultancy services; evaluation of chemical analyses by engineers and scientists, and its technological consultancy services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 18, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFujirebio Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameFujirebio Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameFujirebio Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Monday, March 4, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 9, 2024FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 9, 2024FINAL DISPOSITION PROCESSED
Wednesday, February 7, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, February 2, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, November 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 7, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, August 22, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 22, 2023PUBLISHED FOR OPPOSITION
Monday, August 21, 2023NOTIFICATION PROCESSED BY IB
Wednesday, August 2, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 2, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 2, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 18, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, July 18, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 18, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, July 18, 2023EXAMINERS AMENDMENT -WRITTEN
Friday, July 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 26, 2023REFUSAL PROCESSED BY IB
Tuesday, June 6, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, June 6, 2023REFUSAL PROCESSED BY MPU
Saturday, April 8, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 7, 2023NON-FINAL ACTION WRITTEN
Tuesday, March 21, 2023ASSIGNED TO EXAMINER
Tuesday, October 11, 2022APPLICATION FILING RECEIPT MAILED
Friday, October 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 6, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB